The principal findings of this study were that both high average SLC6A4 methylation values and SI at 2 weeks predicted worse long-term stroke outcomes, i.e., composite CCVEs and recurrent stroke, at 8–14 years after stroke, independent of covariates. This evidence concerns the gene SLC6A4 and stroke disorder.